Pulmatrix Corporation (PULM) Company Cash on Hand

PULM (Pulmatrix Inc) - company brandmark

The current cash position of Pulmatrix, Inc. (PULM) demonstrates the impact of clinical trials and partnerships on liquidity, yet the long-term protection of iSPERSE and stringent FDA regulations create a robust defensive barrier. The value has stabilized at 0.00, confirming the business's resilience to market cycles driven by steady demand for innovation. The cash dynamics on this chart reveal hidden costs and the company's actual margin of safety.

Company Cash Balance: Pulmatrix Inc (PULM) for 07/04/2022 - 11/21/2026

Pulmatrix Corp (PULM) - metric breakdowns and financial figures

Fundamental valuation:pulmatrix.com
Product sample of Pulmatrix Inc

This metric reflects the total volume of liquid assets and cash equivalents, determining the business's financial autonomy and its ability to cover operating expenses without resorting to external borrowing. By analyzing the cash balance of Pulmatrix, Inc. (PULM), an investor can see the company's critical safety margin, which, in the absence of commercial products, serves as the sole guarantee for the completion of costly clinical trials for inhalation drugs.

Main competitors

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Company Cash Volume|Company Cash Funds QNTM|Company Cash Volume FGEN|Company Cash on Hand Telomir Pharmaceuticals TELO|Company Cash Volume RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Company Total Cash Volume|RLYB - Company Cash Funds|LEXX (Lexaria Bioscience Corp.) - Company Cash and Cash Equivalents|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance